# The PIFPAF-PFA Study

> **NCT05986526** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 206 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Pulmonary vein isolation without posterior wall ablation
- **PROCEDURE:** Pulmonary vein isolation with posterior wall ablation

## Key facts

- **NCT ID:** NCT05986526
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-13
- **Primary completion:** 2026-02-13
- **Final completion:** 2028-02-13
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05986526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05986526, "The PIFPAF-PFA Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05986526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*